Studies in mice showed that Asxl1 haploinsufficiency leads to a reduced hematopoietic stem cell pool, decreased hematopoietic repopulating capacity, and mild features of MDS [25]. This evidence concerns the gene ASXL1 and myelodysplastic syndrome.